David Vesole MD in Hackensack, New Jersey

Home New Jersey Hackensack

David Vesole MD has Hematology/oncology as his primary medical specialty. Their primary office is: 92 2nd St in Hackensack, New Jersey. There is an additional office location, for a total of two, for David Vesole MD that can be viewed further down.

They're a part of the: Regional Cancer Care Associates Llc medical group which has around 111 members. You can call their office at 201-996-5900 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Northwestern University Feinberg Medical School and graduated in 1984 (around 40 years of experience). They are listed as doing telehealth appointments.

David H Vesole MD Office Phone and Directions

David Vesole MD
Regional Cancer Care Associates Llc
92 2nd St
Hackensack, New Jersey 07601
201-996-5900

Patient Ratings
Please rate your experience with David Vesole MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 201-996-5900

Enter a starting address:

Healthcare Info for David Vesole MD

Medical School: Northwestern University Feinberg Medical School
Graduation Year: 1984
The Primary Medical Specialty for David Vesole MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 40
PAC (PECOS ID)#: 1052332244
NPI #: 1790773356
NPI Created On: 10/07/2005
NPI Last Updated Listed as: 01/26/2022
Primary Taxonomy Code: 207RH0000X
License Number:
25MA08625200
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

AmeriHealth New Jersey
Blue Cross Blue Shield
CareFirst BlueChoice, Inc.
Humana
Group Hospitalization and Medical Services Inc.
Oscar Garden State Insurance Corporation
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: Spanish, Italian,Russian,Spanish, English,Spanish, English.

Services and Procedures include:

Transplantation of patient's bone marrow or blood-derived stem cells
Complete blood cell count (red cells, white blood cell, platelets), automated test
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
New patient office or other outpatient visit, typically 60 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Hospital discharge day management, more than 30 minutes
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
Injection, epoetin alfa, (for non-esrd use), 1000 units
Injection, pegfilgrastim, 6 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $1,200

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788687595

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $1,200

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788687597

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $600

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788687599

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $1,200

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788687601

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $1,350

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788687603

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788687605

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $1,350

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788687607

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $1,013

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788687609

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $1,350

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 788687611

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Payments Total: $125

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788687613

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Additional Office Locations

1. Regional Cancer Care Associates Llc
3970 Reservoir Rd Nw
Washington, DC 20007
Group Members: 111

Phone: 201-996-5900

Enter a starting address:

Hematology/oncology Professionals in Hackensack

1.
Mark Pascal

92 2nd St
Hackensack, NJ
Regional Cancer Care Associates Llc

2.
Richard Scher DO

30 Prospect Ave
Hackensack, NJ
Regional Cancer Care Associates Llc

3.
Harry Harper

92 2nd St
Hackensack, NJ
Regional Cancer Care Associates Llc

4.
Sukhdeep Kaur

92 2nd St
Hackensack, NJ
Regional Cancer Care Associates Llc

5.
Robert Tassan MD

30 Prospect Ave
Hackensack, NJ
Regional Cancer Care Associates Llc

6.
Kelley Mowatt Pesce

92 2nd St
Hackensack, NJ
Regional Cancer Care Associates Llc

Providers in Regional Cancer Care Associates Llc

1.May Abdo-matkiwsky Do

30 Prospect Ave
Hackensack Nj 07601-1915
Regional Cancer Care Associates Llc
Hematology/oncology

2.May Abdo-matkiwsky Do

89 Sparta Ave
Sparta Nj 07871-1791
Regional Cancer Care Associates Llc
Hematology/oncology

3.Manmeet Ahluwalia

57 Kent Rd
Howell Nj 07731-2452
Regional Cancer Care Associates Llc
Hematology/oncology

4.Manmeet Ahluwalia

40 Bey Lea Rd
Toms River Nj 08753-2900
Regional Cancer Care Associates Llc
Hematology/oncology

5.Kaleem Ahmad

30 Prospect Ave
Hackensack Nj 07601-1915
Regional Cancer Care Associates Llc
Hematology/oncology

6.Kaleem Ahmad

210 Route Us 9 S 106
Marmora Nj 08223-1271
Regional Cancer Care Associates Llc
Hematology/oncology

View all 111 members of Regional Cancer Care Associates Llc medical group